Acute Promyelocytic Leukemia With PML-RARANCT03253848
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia
A study testing Simplified Patient Care Strategy and Laboratory Biomarker Analysis in people with Acute Promyelocytic Leukemia With PML-RARA and t(15;17), run by ECOG-ACRIN Cancer Research Group at 294 sites in 2 countries.
Trial summary
This clinical trial studies how well simplified patient care strategy works in decreasing early death in patients with acute promyelocytic leukemia. Implementing simplified acute promyelocytic leukemia guidelines along with support from acute promyelocytic leukemia experts may decrease deaths and improve survival. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Acute Promyelocytic Leukemia With PML-RARA, t(15;17)
- What is being tested?
- Simplified Patient Care Strategy and Laboratory Biomarker Analysis
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 202 participants
- Where
- 294 sitesin 2 countries
- Study dates
- 26 Sep 2017to 31 Dec 2027
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Confirmed to have a diagnosis of APL, which is defined as:
- Positive t(15:17) by fluorescence in situ hybridization (FISH) or conventional karyotype
- Positive promyelocytic leukemia/retinoic acid receptor PML/RAR alpha by polymerase chain reaction (PCR)
- Patients must accept treatment and supportive care guidelines
- Referrals must be made as early as possible but no later than 5 calendar days after ATRA therapy is initiated; consent can be obtained up till day 7 or earlier
- Co-management can be started as soon as referral is made including weekends; the physician at the outlying facility should make every effort to call the APL expert at the first suspicion of APL
Who cannot join
None listed.
Trial locations and contacts
294 sites in 2 countries.
294 sites in 2 countries
United States282 sites
Riverwood Healthcare Center
Aitkin, Minnesota, 56431
Phoebe Putney Memorial Hospital
Albany, Georgia, 31701
American Fork Hospital / Huntsman Intermountain Cancer Center
American Fork, Utah, 84003
Mary Greeley Medical Center
Ames, Iowa, 50010
McFarland Clinic PC - Ames
Ames, Iowa, 50010
Kaiser Permanente-Anaheim
Anaheim, California, 92806
Kaiser Permanente-Deer Valley Medical Center
Antioch, California, 94531
ThedaCare Regional Cancer Center
Appleton, Wisconsin, 54911
AdventHealth Infusion Center Asheville
Asheville, North Carolina, 28803
Duluth Clinic Ashland
Ashland, Wisconsin, 54806
Northwest Wisconsin Cancer Center
Ashland, Wisconsin, 54806
University Cancer and Blood Center LLC
Athens, Georgia, 30607
MultiCare Auburn Medical Center
Auburn, Washington, 98001
Augusta University Medical Center
Augusta, Georgia, 30912
Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, 80012
The Medical Center of Aurora
Aurora, Colorado, 80012
Kaiser Permanente-Baldwin Park
Baldwin Park, California, 91706
Kaiser Permanente-Bellflower
Bellflower, California, 90706
Sanford Joe Lueken Cancer Center
Bemidji, Minnesota, 56601
Saint Vincent Healthcare
Billings, Montana, 59101
Saint Vincent Frontier Cancer Center
Billings, Montana, 59102
Sanford Bismarck Medical Center
Bismarck, North Dakota, 58501
Illinois CancerCare-Bloomington
Bloomington, Illinois, 61704
Central Care Cancer Center - Bolivar
Bolivar, Missouri, 65613
Parkland Health Center-Bonne Terre
Bonne Terre, Missouri, 63628
McFarland Clinic PC-Boone
Boone, Iowa, 50036
Boulder Community Hospital
Boulder, Colorado, 80301
Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, 80304
Essentia Health Saint Joseph's Medical Center
Brainerd, Minnesota, 56401
Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, 19010
Aurora Cancer Care-Southern Lakes VLCC
Burlington, Wisconsin, 53105
Fairview Ridges Hospital
Burnsville, Minnesota, 55337
Minnesota Oncology - Burnsville
Burnsville, Minnesota, 55337
Saint James Community Hospital and Cancer Treatment Center
Butte, Montana, 59701
Cambridge Medical Center
Cambridge, Minnesota, 55008
Illinois CancerCare-Canton
Canton, Illinois, 61520
Saint Francis Medical Center
Cape Girardeau, Missouri, 63703
Southeast Cancer Center
Cape Girardeau, Missouri, 63703
Memorial Hospital of Carbondale
Carbondale, Illinois, 62902
SIH Cancer Institute
Carterville, Illinois, 62918
Illinois CancerCare-Carthage
Carthage, Illinois, 62321
Sandra L Maxwell Cancer Center
Cedar City, Utah, 84720
Rocky Mountain Cancer Centers - Centennial
Centennial, Colorado, 80112
Centralia Oncology Clinic
Centralia, Illinois, 62801
Cancer Center of Kansas - Chanute
Chanute, Kansas, 66720
Cheyenne Regional Medical Center-West
Cheyenne, Wyoming, 82001
Northwestern University
Chicago, Illinois, 60611
John H Stroger Jr Hospital of Cook County
Chicago, Illinois, 60612
AdventHealth Infusion Center Haywood
Clyde, North Carolina, 28721
Main Line Health Center-Collegeville
Collegeville, Pennsylvania, 19426
Mercy Hospital
Coon Rapids, Minnesota, 55433
Aurora Saint Luke's South Shore
Cudahy, Wisconsin, 53110
Geisinger Medical Center
Danville, Pennsylvania, 17822
Dekalb Medical Center
Decatur, Georgia, 30033
Cancer Care Specialists of Illinois - Decatur
Decatur, Illinois, 62526
Decatur Memorial Hospital
Decatur, Illinois, 62526
Essentia Health - Deer River Clinic
Deer River, Minnesota, 56636
Cancer Center of Colorado at Sloan's Lake
Denver, Colorado, 80204
Denver Health Medical Center
Denver, Colorado, 80204
National Jewish Health-Main Campus
Denver, Colorado, 80206
The Women's Imaging Center
Denver, Colorado, 80209
Colorado Blood Cancer Institute
Denver, Colorado, 80218
Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, 80218
Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, 80218
SCL Health Saint Joseph Hospital
Denver, Colorado, 80218
Rocky Mountain Cancer Centers-Rose
Denver, Colorado, 80220
Rose Medical Center
Denver, Colorado, 80220
Essentia Health Saint Mary's - Detroit Lakes Clinic
Detroit Lakes, Minnesota, 56501
Illinois CancerCare-Dixon
Dixon, Illinois, 61021
Cancer Center of Kansas - Dodge City
Dodge City, Kansas, 67801
Essentia Health Cancer Center
Duluth, Minnesota, 55805
Essentia Health Saint Mary's Medical Center
Duluth, Minnesota, 55805
Miller-Dwan Hospital
Duluth, Minnesota, 55805
Marshfield Medical Center-EC Cancer Center
Eau Claire, Wisconsin, 54701
Fairview Southdale Hospital
Edina, Minnesota, 55435
Crossroads Cancer Center
Effingham, Illinois, 62401
Cancer Center of Kansas - El Dorado
El Dorado, Kansas, 67042
Mountain Blue Cancer Care Center - Swedish
Englewood, Colorado, 80113
Swedish Medical Center
Englewood, Colorado, 80113
Illinois CancerCare-Eureka
Eureka, Illinois, 61530
Main Line Health Center-Exton
Exton, Pennsylvania, 19341
Fairbanks Memorial Hospital
Fairbanks, Alaska, 99701
Essentia Health Cancer Center-South University Clinic
Fargo, North Dakota, 58103
Sanford South University Medical Center
Fargo, North Dakota, 58103
Sanford Broadway Medical Center
Fargo, North Dakota, 58122
Sanford Roger Maris Cancer Center
Fargo, North Dakota, 58122
Parkland Health Center - Farmington
Farmington, Missouri, 63640
Lake Region Healthcare Corporation-Cancer Care
Fergus Falls, Minnesota, 56537
Aurora Health Center-Fond du Lac
Fond du Lac, Wisconsin, 54937
Kaiser Permanente-Fontana
Fontana, California, 92335
McFarland Clinic PC-Trinity Cancer Center
Fort Dodge, Iowa, 50501
Cancer Center of Kansas - Fort Scott
Fort Scott, Kansas, 66701
Essentia Health - Fosston
Fosston, Minnesota, 56542
Kaiser Permanente-Fremont
Fremont, California, 94538
Fresno Cancer Center
Fresno, California, 93720
Kaiser Permanente-Fresno
Fresno, California, 93720
Unity Hospital
Fridley, Minnesota, 55432
Gibbs Cancer Center-Gaffney
Gaffney, South Carolina, 29341
Illinois CancerCare-Galesburg
Galesburg, Illinois, 61401
Western Illinois Cancer Treatment Center
Galesburg, Illinois, 61401
Central Care Cancer Center - Garden City
Garden City, Kansas, 67846
Aurora Health Care Germantown Health Center
Germantown, Wisconsin, 53022
MultiCare Gig Harbor Medical Park
Gig Harbor, Washington, 98335
National Jewish Health-Western Hematology Oncology
Golden, Colorado, 80401
Aurora Cancer Care-Grafton
Grafton, Wisconsin, 53024
Saint Mary's Hospital and Regional Medical Center
Grand Junction, Colorado, 81501
Central Care Cancer Center - Great Bend
Great Bend, Kansas, 67530
North Colorado Medical Center
Greeley, Colorado, 80631
Aurora BayCare Medical Center
Green Bay, Wisconsin, 54311
Saint Francis Hospital
Greenville, South Carolina, 29601
Saint Francis Cancer Center
Greenville, South Carolina, 29607
Rocky Mountain Cancer Centers-Greenwood Village
Greenwood Village, Colorado, 80111
Gibbs Cancer Center-Pelham
Greer, South Carolina, 29651
Kaiser Permanente - Harbor City
Harbor City, California, 90710
AdventHealth Hendersonville
Hendersonville, North Carolina, 28792
Essentia Health Hibbing Clinic
Hibbing, Minnesota, 55746
Kaiser Permanente Moanalua Medical Center
Honolulu, Hawaii, 96819
Cancer Center of Kansas-Independence
Independence, Kansas, 67301
Centerpoint Medical Center LLC
Independence, Missouri, 64057
Kaiser Permanente-Irvine
Irvine, California, 92618
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980
Essentia Health - Jamestown Clinic
Jamestown, North Dakota, 58401
McFarland Clinic PC-Jefferson
Jefferson, Iowa, 50129
Capital Region Southwest Campus
Jefferson City, Missouri, 65109
Research Medical Center
Kansas City, Missouri, 64132
Aurora Cancer Care-Kenosha South
Kenosha, Wisconsin, 53142
Illinois CancerCare-Kewanee Clinic
Kewanee, Illinois, 61443
Cancer Center of Kansas-Kingman
Kingman, Kansas, 67068
Gundersen Lutheran Medical Center
La Crosse, Wisconsin, 54601
Good Samaritan Medical Center
Lafayette, Colorado, 80026
Lawrence Memorial Hospital
Lawrence, Kansas, 66044
Kansas Institute of Medicine Cancer and Blood Center
Lenexa, Kansas, 66219
Minimally Invasive Surgery Hospital
Lenexa, Kansas, 66219
Cancer Center of Kansas-Liberal
Liberal, Kansas, 67905
Rocky Mountain Cancer Centers-Littleton
Littleton, Colorado, 80120
Logan Regional Hospital
Logan, Utah, 84321
Rocky Mountain Cancer Centers-Sky Ridge
Lone Tree, Colorado, 80124
Sky Ridge Medical Center
Lone Tree, Colorado, 80124
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, 90027
Kaiser Permanente-Cadillac
Los Angeles, California, 90034
McKee Medical Center
Loveland, Colorado, 80539
Illinois CancerCare-Macomb
Macomb, Illinois, 61455
Cancer Center of Kansas-Manhattan
Manhattan, Kansas, 66502
Fairview Clinics and Surgery Center Maple Grove
Maple Grove, Minnesota, 55369
Minnesota Oncology Hematology PA-Maplewood
Maplewood, Minnesota, 55109
Saint John's Hospital - Healtheast
Maplewood, Minnesota, 55109
Aurora Bay Area Medical Group-Marinette
Marinette, Wisconsin, 54143
McFarland Clinic PC-Marshalltown
Marshalltown, Iowa, 50158
Marshfield Medical Center-Marshfield
Marshfield, Wisconsin, 54449
Cancer Center of Kansas - McPherson
McPherson, Kansas, 67460
Riddle Memorial Hospital
Media, Pennsylvania, 19063
Baptist Memorial Hospital and Cancer Center-Memphis
Memphis, Tennessee, 38120
Aurora Cancer Care-Milwaukee
Milwaukee, Wisconsin, 53209
Aurora Saint Luke's Medical Center
Milwaukee, Wisconsin, 53215
Aurora Sinai Medical Center
Milwaukee, Wisconsin, 53233
Abbott-Northwestern Hospital
Minneapolis, Minnesota, 55407
Hennepin County Medical Center
Minneapolis, Minnesota, 55415
Health Partners Inc
Minneapolis, Minnesota, 55454
Marshfield Clinic-Minocqua Center
Minocqua, Wisconsin, 54548
Kaiser Permanente-Modesto
Modesto, California, 95356
Monticello Cancer Center
Monticello, Minnesota, 55362
Intermountain Medical Center
Murray, Utah, 84107
Ochsner Medical Center Jefferson
New Orleans, Louisiana, 70121
Cancer Center of Western Wisconsin
New Richmond, Wisconsin, 54017
New Ulm Medical Center
New Ulm, Minnesota, 56073
Memorial Sloan Kettering Cancer Center
New York, New York, 10065
Cancer Center of Kansas - Newton
Newton, Kansas, 67114
Cancer Care Center of O'Fallon
O'Fallon, Illinois, 62269
Kaiser Permanente Oakland-Broadway
Oakland, California, 94611
Kaiser Permanente-Oakland
Oakland, California, 94611
McKay-Dee Hospital Center
Ogden, Utah, 84403
Kaiser Permanente-Ontario
Ontario, California, 91761
Vince Lombardi Cancer Clinic - Oshkosh
Oshkosh, Wisconsin, 54904
Illinois CancerCare-Ottawa Clinic
Ottawa, Illinois, 61350
Menorah Medical Center
Overland Park, Kansas, 66209
Kaiser Permanente - Panorama City
Panorama City, California, 91402
Paoli Memorial Hospital
Paoli, Pennsylvania, 19301
Essentia Health - Park Rapids
Park Rapids, Minnesota, 56470
Cancer Center of Kansas - Parsons
Parsons, Kansas, 67357
Illinois CancerCare-Pekin
Pekin, Illinois, 61554
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
Pekin, Illinois, 61554
Illinois CancerCare-Peoria
Peoria, Illinois, 61615
OSF Saint Francis Radiation Oncology at Peoria Cancer Center
Peoria, Illinois, 61615
Methodist Medical Center of Illinois
Peoria, Illinois, 61636
OSF Saint Francis Medical Center
Peoria, Illinois, 61637
Illinois CancerCare-Peru
Peru, Illinois, 61354
Valley Radiation Oncology
Peru, Illinois, 61354
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104
Jefferson Healthcare
Port Townsend, Washington, 98368
Cancer Center of Kansas - Pratt
Pratt, Kansas, 67124
Illinois CancerCare-Princeton
Princeton, Illinois, 61356
Fairview Northland Medical Center
Princeton, Minnesota, 55371
Utah Valley Regional Medical Center
Provo, Utah, 84604
MultiCare Good Samaritan Hospital
Puyallup, Washington, 98372
Aurora Cancer Care-Racine
Racine, Wisconsin, 53406
Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, 95670
Kaiser Permanente-Redwood City
Redwood City, California, 94063
Lakeview Medical Center-Marshfield Clinic
Rice Lake, Wisconsin, 54868
Marshfield Medical Center-Rice Lake
Rice Lake, Wisconsin, 54868
Kaiser Permanente-Richmond
Richmond, California, 94801
Kaiser Permanente-Riverside
Riverside, California, 92505
Riverton Hospital
Riverton, Utah, 84065
North Memorial Medical Health Center
Robbinsdale, Minnesota, 55422
Mayo Clinic in Rochester
Rochester, Minnesota, 55905
Rohnert Park Cancer Center
Rohnert Park, California, 94928
Kaiser Permanente-Roseville
Roseville, California, 95661
The Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, 95678
Kaiser Permanente Downtown Commons
Sacramento, California, 95814
Kaiser Permanente-South Sacramento
Sacramento, California, 95823
South Sacramento Cancer Center
Sacramento, California, 95823
Kaiser Permanente - Sacramento
Sacramento, California, 95825
Park Nicollet Clinic - Saint Louis Park
Saint Louis Park, Minnesota, 55416
Regions Hospital
Saint Paul, Minnesota, 55101
United Hospital
Saint Paul, Minnesota, 55102
Sainte Genevieve County Memorial Hospital
Sainte Genevieve, Missouri, 63670
Cancer Center of Kansas - Salina
Salina, Kansas, 67401
Utah Cancer Specialists-Salt Lake City
Salt Lake City, Utah, 84106
LDS Hospital
Salt Lake City, Utah, 84143
Kaiser Permanente-San Diego Mission
San Diego, California, 92108
Kaiser Permanente-San Diego Zion
San Diego, California, 92120
Kaiser Permanente-San Francisco
San Francisco, California, 94115
Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, 95119
Kaiser Permanente San Leandro
San Leandro, California, 94577
Kaiser Permanente-San Marcos
San Marcos, California, 92078
Kaiser San Rafael-Gallinas
San Rafael, California, 94903
Essentia Health Sandstone
Sandstone, Minnesota, 55072
Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, 95051
Kaiser Permanente-Santa Rosa
Santa Rosa, California, 95403
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Savannah, Georgia, 31405
Low Country Cancer Care Associates PC
Savannah, Georgia, 31405
Summit Cancer Care-Candler
Savannah, Georgia, 31405
Saint Francis Regional Medical Center
Shakopee, Minnesota, 55379
Vince Lombardi Cancer Clinic-Sheboygan
Sheboygan, Wisconsin, 53081
Siouxland Regional Cancer Center
Sioux City, Iowa, 51101
Sanford Cancer Center Oncology Clinic
Sioux Falls, South Dakota, 57104
Sanford USD Medical Center - Sioux Falls
Sioux Falls, South Dakota, 57117-5134
Kaiser Permanente Cancer Treatment Center
South San Francisco, California, 94080
Kaiser Permanente-South San Francisco
South San Francisco, California, 94080
Spartanburg Medical Center
Spartanburg, South Carolina, 29303
MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
Spokane, Washington, 99204
MultiCare Deaconess Cancer and Blood Specialty Center - North
Spokane, Washington, 99218
MultiCare Deaconess Cancer and Blood Specialty Center - Valley
Spokane Valley, Washington, 99216
Southern Illinois University School of Medicine
Springfield, Illinois, 62702
Springfield Clinic
Springfield, Illinois, 62702
Memorial Medical Center
Springfield, Illinois, 62781
Missouri Baptist Medical Center
St Louis, Missouri, 63131
Dixie Medical Center Regional Cancer Center
St. George, Utah, 84770
Marshfield Clinic Stevens Point Center
Stevens Point, Wisconsin, 54482
Lakeview Hospital
Stillwater, Minnesota, 55082
Kaiser Permanente-Stockton
Stockton, California, 95210
Missouri Baptist Sullivan Hospital
Sullivan, Missouri, 63080
Aurora Medical Center in Summit
Summit, Wisconsin, 53066
Missouri Baptist Outpatient Center-Sunset Hills
Sunset Hills, Missouri, 63127
Southwest Illinois Health Services LLP
Swansea, Illinois, 62226
Mary Bridge Children's Hospital and Health Center
Tacoma, Washington, 98405
MultiCare Tacoma General Hospital
Tacoma, Washington, 98405
Sanford Thief River Falls Medical Center
Thief River Falls, Minnesota, 56701
National Jewish Health-Northern Hematology Oncology
Thornton, Colorado, 80260
Vince Lombardi Cancer Clinic-Two Rivers
Two Rivers, Wisconsin, 54241
MGC Hematology Oncology-Union
Union, South Carolina, 29379
Kaiser Permanente Medical Center-Vacaville
Vacaville, California, 95688
Kaiser Permanente-Vallejo
Vallejo, California, 94589
Essentia Health Virginia Clinic
Virginia, Minnesota, 55792
Ridgeview Medical Center
Waconia, Minnesota, 55387
Kaiser Permanente-Walnut Creek
Walnut Creek, California, 94596
Aurora Cancer Care-Milwaukee West
Wauwatosa, Wisconsin, 53226
Cancer Center of Kansas - Wellington
Wellington, Kansas, 67152
Aurora West Allis Medical Center
West Allis, Wisconsin, 53227
Marshfield Medical Center - Weston
Weston, Wisconsin, 54476
SCL Health Lutheran Medical Center
Wheat Ridge, Colorado, 80033
Associates In Womens Health
Wichita, Kansas, 67208
Cancer Center of Kansas-Wichita Medical Arts Tower
Wichita, Kansas, 67208
Ascension Via Christi Hospitals Wichita
Wichita, Kansas, 67214
Cancer Center of Kansas - Wichita
Wichita, Kansas, 67214
Wesley Medical Center
Wichita, Kansas, 67214
Rice Memorial Hospital
Willmar, Minnesota, 56201
Cancer Center of Kansas - Winfield
Winfield, Kansas, 67156
Minnesota Oncology Hematology PA-Woodbury
Woodbury, Minnesota, 55125
Kaiser Permanente-Woodland Hills
Woodland Hills, California, 91367
Sanford Cancer Center Worthington
Worthington, Minnesota, 56187
Lankenau Medical Center
Wynnewood, Pennsylvania, 19096
Fairview Lakes Medical Center
Wyoming, Minnesota, 55092
Puerto Rico12 sites
Advance Oncology Center
Aguadilla, 00603
Doctor's Cancer Center-Arecibo
Arecibo, 00614
Cancer Center-Metro Medical Center Bayamon
Bayamón, 00959-5060
Hematologia Oncologia San Pablo
Bayamón, 00961
HIMA San Pablo Oncologic Hospital
Caguas, 00726
Doctors Cancer Center
Manati, 00674
Instituto Oncologia Moderna Ponce
Ponce, 00716
San Juan Community Oncology Group
San Juan, 00917
Primary Care Physician Group
San Juan, 00920
Centro Comprensivo de Cancer de UPR
San Juan, 00927
San Juan City Hospital
San Juan, 00936
Centro de Hematologia y Oncologia del Sur
Santa Isabel, 00757
About this study
Official title: A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)
This clinical trial studies how well simplified patient care strategy works in decreasing early death in patients with acute promyelocytic leukemia. Implementing simplified acute promyelocytic leukemia guidelines along with support from acute promyelocytic leukemia experts may decrease deaths and improve survival.
Read the detailed description
PRIMARY OBJECTIVES:
- To evaluate if the proposed patient care strategy, that includes use of simplified guidelines along with acute promyelocytic leukemia (APL) expert support, decreases the one-month induction mortality rate from 30% to under 15%.
SECONDARY OBJECTIVES:
- To assess the overall survival 1 year after accrual is completed. II. To assess incidence and severity of differentiation syndrome. III. To correlate outcomes with time to initiation of all-trans retinoic acid (ATRA) from diagnosis or suspicion of diagnosis.
IV. To compare outcomes between academic and community centers separately. V. To evaluate factors associated with outcome.
OUTLINE:
Patients receive standard of care treatment for APL. Patients and doctors regularly discuss with an APL expert to identify and mange treatment.
After diagnosis, patients are followed up for 1 year.
- Being tested
- Simplified Patient Care Strategy, Laboratory Biomarker Analysis
- Medical subject headings
- Leukemia, Promyelocytic, Acute
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Simplified Patient Care StrategyOther
Treatment per Acute Promyelocytic Leukemia (APL) Treatment Guidelines plus discussion between doctors and APL expert
Laboratory Biomarker AnalysisOther
Correlative studies
| Study group | Role | What they receive |
|---|---|---|
| Simplified Patient Care Strategy plus APL Expert Support | Experimental | Patients receive standard of care treatment for APL. Treating physicians regularly discuss with an APL expert to identify and mange treatment. Receives: Other: Simplified Patient Care Strategy; Other: Laboratory Biomarker Analysis |
What is being measured
The primary outcome is the main question the study is designed to answer.
One-month Mortality Rate
Proportion of patients died within one month from the first date of induction therapy.
Measured: Assessed at one month
Secondary outcomes (5)
Survival Rate at One Year
Overall survival is defined as the time from the first date of induction therapy to death or date last known alive. Proportion of patients alive at one year was estimated using the method of Kaplan and Meier.
Measured: Assessed at one year
One-month Survival Rate by Lead Academic Sites and Community Sites
Proportion of patients who are alive at one month since the first date of induction therapy by lead academic sites and community sites
Measured: Assessed at one month
Differentiation Syndrome Rate
The proportion of patients with differentiation syndrome (measured based on the CTC version 4.0) will be evaluated.
Measured: Assessed up to 1 year
Association Between One-month Mortality Rate and Time From Diagnosis to Initiation of All-trans Retinoic Acid (ATRA)
The time from diagnosis and initiation of ATRA will be assessed and dichotomized as "short' vs. "long" using the median value. One-month mortality rate will be compared in these two groups (short vs. long) using the Fisher's exact test.
Measured: Assessed at one month
Association Between One-month Survival and Baseline Factors
The associations between one-month survival and baseline factors will be evaluated.
Measured: Assessed at baseline and one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Aug 2017
- Study start26 Sep 2017
- Primary completion27 Apr 2023
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Acute Promyelocytic Leukemia With PML-RARAStudies of the same condition, open and under way.
- More trials run by ECOG-ACRIN Cancer Research GroupThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 202 participants (actual)
Sponsor and investigators
- Lead sponsor
- ECOG-ACRIN Cancer Research Group
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Sponsor
- Investigators
- Anand Jillella, Principal investigator, ECOG-ACRIN Cancer Research Group
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03253848
- Sponsor's protocol ID
- EA9131
- Other IDs
- NCI-2016-01123, EA9131, EA9131, UG1CA189828, U10CA037403
- Status last verified
- Jul 2026
- First submitted
- 16 Aug 2017
- Last updated
- 6 Aug 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.
Publications
Jillella AP, Lee SJ, Altman JK, Luger SM, Tallman MS, Foran JM, Bradshaw D, Law LY, Bryan LJ, Abou Zahr A, Begna KH, Perl AE, Vadakara JJL, Qamar R, Bergan RC, Fisch MJ, Carlos RC, Wagner LI, Kota VK, Litzow MR. Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial. JAMA Oncol. 2025 Feb 27;11(4):400-7. doi: 10.1001/jamaoncol.2024.7033. Online ahead of print.
PubMed 40014329
Study at a glance
From the registry record, last updated by the sponsor on 6 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)
- ClinicalTrials.gov ID
- NCT03253848
- Acronym / sponsor ID
- EA9131
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 202 participants (actual)
- Lead sponsor
- ECOG-ACRIN Cancer Research GroupResearch network
- Collaborators
- National Cancer Institute (NCI)
- Study start
- 26 Sep 2017 (actual)
- Primary completion
- 27 Apr 2023 (actual)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 18 Aug 2017 (actual)
- Results
- Posted 11 Apr 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This clinical trial studies how well simplified patient care strategy works in decreasing early death in patients with acute promyelocytic leukemia. Implementing simplified acute promyelocytic leukemia guidelines along with support from acute promyelocytic leukemia experts may decrease deaths and improve survival.
Detailed description
PRIMARY OBJECTIVES:
- To evaluate if the proposed patient care strategy, that includes use of simplified guidelines along with acute promyelocytic leukemia (APL) expert support, decreases the one-month induction mortality rate from 30% to under 15%.
SECONDARY OBJECTIVES:
- To assess the overall survival 1 year after accrual is completed. II. To assess incidence and severity of differentiation syndrome. III. To correlate outcomes with time to initiation of all-trans retinoic acid (ATRA) from diagnosis or suspicion of diagnosis.
IV. To compare outcomes between academic and community centers separately. V. To evaluate factors associated with outcome.
OUTLINE:
Patients receive standard of care treatment for APL. Patients and doctors regularly discuss with an APL expert to identify and mange treatment.
After diagnosis, patients are followed up for 1 year.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Simplified Patient Care Strategy plus APL Expert Support | Experimental | Other: Simplified Patient Care Strategy, Other: Laboratory Biomarker AnalysisPatients receive standard of care treatment for APL. Treating physicians regularly discuss with an APL expert to identify and mange treatment. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Confirmed to have a diagnosis of APL, which is defined as:
- Patients must accept treatment and supportive care guidelines
- Referrals must be made as early as possible but no later than 5 calendar days after ATRA therapy is initiated; consent can be obtained up till day 7 or earlier
- Co-management can be started as soon as referral is made including weekends; the physician at the outlying facility should make every effort to call the APL expert at the first suspicion of APL
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Simplified Patient Care StrategyTreatment per Acute Promyelocytic Leukemia (APL) Treatment Guidelines plus discussion between doctors and APL expert | Other | Simplified Patient Care Strategy plus APL Expert Support |
| Laboratory Biomarker AnalysisCorrelative studies | Other | Simplified Patient Care Strategy plus APL Expert Support |
Primary outcome
One-month Mortality Rate
Time frame: Assessed at one month
Proportion of patients died within one month from the first date of induction therapy.
5 secondary outcomes
Survival Rate at One Year
Time frame: Assessed at one year
One-month Survival Rate by Lead Academic Sites and Community Sites
Time frame: Assessed at one month
Differentiation Syndrome Rate
Time frame: Assessed up to 1 year
Association Between One-month Mortality Rate and Time From Diagnosis to Initiation of All-trans Retinoic Acid (ATRA)
Time frame: Assessed at one month
Association Between One-month Survival and Baseline Factors
Time frame: Assessed at baseline and one month
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Aug 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 40014329Jillella AP, Lee SJ, Altman JK, Luger SM, Tallman MS, Foran JM, Bradshaw D, Law LY, Bryan LJ, Abou Zahr A, Begna KH, Perl AE, Vadakara JJL, Qamar R, Bergan RC, Fisch MJ, Carlos RC, Wagner LI, Kota VK, Litzow MR. Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial. JAMA Oncol. 2025 Feb 27;11(4):400-7. doi: 10.1001/jamaoncol.2024.7033. Online ahead of print.
- Individual participant dataSharing planned: Yes. Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.
Related trials for Acute Promyelocytic Leukemia With PML-RARA
RecruitingPhase 3
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia
RecruitingPhase 1
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid Leukemia, Acute Promyelocytic Leukemia With PML-RARA
RecruitingPhase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia With PML-RARA
Active, not recruitingPhase 3
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
Not yet recruitingPhase 3
A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)
Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anand Jillella principal investigator
ECOG-ACRIN Cancer Research Group
294 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Simplified Patient Care Strategy and Laboratory Biomarker Analysis in people with Acute Promyelocytic Leukemia With PML-RARA and t(15;17), run by ECOG-ACRIN Cancer Research Group at 294 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 6 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 294 sites in United States, Puerto Rico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 11 Apr 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
One-month Mortality Rate (time frame: Assessed at one month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03253848, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2026.